Worldwide pediatric experience with low-dose sultamicillin oral suspension
Open Access
- 31 May 1994
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 55 (5) , 601-613
- https://doi.org/10.1016/s0011-393x(05)80192-4
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Sulbactam/ampicillin followed by oral treatment with sultamicillin for medical and surgical infectionsDiagnostic Microbiology and Infectious Disease, 1989
- Pseudomonas cepacia susceptibility to sulbactamAntimicrobial Agents and Chemotherapy, 1989
- SultamicillinDrugs, 1989
- In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1988
- In vitro antimicrobial spectrum, occurrence of synergy, and recommendations for dilution susceptibility testing concentrations of the cefoperazone-sulbactam combinationJournal of Clinical Microbiology, 1987
- In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and β-lactamase studiesDiagnostic Microbiology and Infectious Disease, 1985
- Pharmacokinetics and bactericidal activity of sultamicillin in infants and childrenJournal of Antimicrobial Chemotherapy, 1985
- Mutual pro-drugs of .BETA.-lactam antibiotics and .BETA.-lactamase inhibitors.The Journal of Antibiotics, 1980
- Antibiotic Susceptibility of Beta-Lactamase-Producing Strains of Branhamella ( Neisseria ) catarrhalisAntimicrobial Agents and Chemotherapy, 1980
- CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological CharacterizationAntimicrobial Agents and Chemotherapy, 1978